A plug-based microfluidic approach was used to perform multiple agglutination assays in parallel without cross-contamination and using only microliter volumes of blood. To perform agglutination assays on-chip, a microfluidic device was designed to combine aqueous streams of antibody, buffer, and red blood cells (RBCs) to form droplets 30-40 nL in volume surrounded by a fluorinated carrier fluid. Using this approach, proof-of-concept ABO and D (Rh) blood typing and group A subtyping were successfully performed by screening against multiple antigens without cross-contamination. On-chip subtyping distinguished common A 1 and A 2 RBCs by using a lectinbased dilution assay. This flexible platform was extended to differentiate rare, weakly agglutinating RBCs of A subtypes by analyzing agglutination avidity as a function of shear rate. Quantitative analysis of changes in contrast within plugs revealed subtleties in agglutination kinetics and enabled characterization of agglutination of rare blood subtypes. Finally, this platform was used to detect bacteria, demonstrating the potential usefulness of this assay in detecting sepsis and the potential for applications in agglutination-based viral detection. The speed, control, and minimal sample consumption provided by this technology present an advance for point of care applications, blood typing of newborns, and general blood assays in small model organisms. This paper reports a plug-based microfluidic approach to perform agglutination assays for ABO and D (Rh factor) blood typing and group A subtyping without cross-contamination. This technology also minimizes sample consumption, an important advance for point of care applications, blood typing of newborns, and general blood assays utilizing mice and other model organisms. When antigens on the surface of red blood cells (RBCs) are exposed to antibodies for that antigen, agglutination, or clumping, of RBCs occurs. These clumps are also referred to as agglutinins. Agglutination is utilized to determine a patient's blood type by indicating the presence of specific antigens on the patient's RBCs. Solid-phase agglutination gel tests are used for greater than 90% of all ABO and D blood typing in emergency rooms and blood banks. 1 The gel tests require microliters of sample, minutes to perform, and give an automated optical readout of agglutination. 2 In addition, disposable plastic cards for point of care applications, microtiter plates, laminar microfluidics, and now molecular approaches to analyze expression of blood group antigens are also used in simple ABO and D blood typing. 3-6 However, both gel-based and card agglutination assays are performed separately for each blood sample, increasing both labor and sample consumption.